bicalutamide

Trials studying bicalutamide

• phase3An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLASactive not recruitingn=1,503
• phase1A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate Cancernot yet recruitingn=56
• phase2Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CTrecruitingn=50
• phase2Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patientsactive not recruitingn=30
• phase2Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancerrecruitingn=53
• phase1Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Canceractive not recruitingn=20
• phase3REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trialrecruitingn=72
• phase2Androgen-responsive POSLUMA-guided Intra-prostatic Boostnot yet recruitingn=23